Navigation Content Footer Global Search Our Work What We Do Disease Areas Prescription Medicines Over-The-Counter Medicines Biopharmaceuticals Partnerships and Collaborations About Us Who We Are Corporate Responsibility Doing Business Responsibly Investor Information Contact Us News All News Media Releases Publications Media Library Stay Up-To-Date Media Contacts Careers Job Search The STEP Trainee Program Working at Sandoz Diversity & Inclusion Making Access Happen Access to Healthcare Stories Sandoz HACk Corporate Responsibility Our corporate responsibility programs are an important part of how we help people around the world access high-quality medicine. Despite the remarkable medical progress during the last century, there are still at least 400 million people worldwide who lack access to essential health services1 and more than two billion who cannot afford to buy the medicines they need2. A healthy life, unfortunately, is still far from a given for too many. Every year, eight million people die from cancer3 and 14 million new cases are diagnosed4. Nearly 10 million people develop tuberculosis (TB) annually, including one million children, and the disease claims 1.5 million victims per year5. Nearly half a million people still die of malaria every year6. Sandoz: Increasing access to high-quality healthcare Video of Sandoz: Increasing access to high-quality healthcare As a division of the Novartis Group, Sandoz is committed to playing a key role in achieving global healthcare goals, by pioneering new approaches to drive increased access worldwide. Increasing access to medicine is the basis of our day-to-day business model, but we also run a range of targeted corporate responsibility programs to ensure access for those most in need. On the following pages, we explain more about the work we do on Corporate Responsibility and the programs we run. We focus on addressing specific health needs in underprivileged communities, including non-communicable and infectious diseases, as well as promoting access to medical information and capacity building through our maternal and child health and Breathe Africa programs. More details can be found by clicking on the links below. In this section Malaria Initiative Together with our partners, and with our continued patient-centric approach, we are committed to the common goal of malaria elimination. Novartis Access The Novartis Access program focuses on affordability and availability of targeted on- and off-patent medicines addressing key non-communicable diseases. New Life, New Hope Improving maternal and child care is a global priority. According to the World Health Organization, young mothers and their children under the age of five are a vulnerable and undertreated population. World Child Cancer Together with World Child Cancer, we are working on improving childhood cancer survival rates in the developing world. Breathe Africa Breathe Africa is a respiratory health program aimed at improving the diagnosis and treatment of respiratory ailments in underprivileged communities. Joint WHO/ World Bank news release; http://www.who.int/mediacentre/news/releases/2015/uhc-report/en/ The 2016 Access to Medicine Index. Methodology 2015; http://apps.who.int/medicinedocs/en/m/abstract/Js22176en/ World Health Organization; http://www.who.int/mediacentre/factsheets/fs297/en/ World Cancer Report 2014; http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports... World Health Organization; http://www.who.int/mediacentre/factsheets/fs104/en/ World Health Organization; http://www.who.int/features/factfiles/malaria/en/ TwitterTweet FacebookShare Share Twitter Facebook Pinterest LinkedIn Google + Email Jump to Comments Print Save Related Links What We Do Investor Information Our Mission and Purpose Access to Healthcare You are here Home › About Us › Sandoz Global Our Work About Us News Careers Locations Contact Us Subscribe to Sandoz Facebook Twitter YouTube LinkedIn RSS Sandoz Site Directory © 2016 Sandoz AG This site is intended for a global audience Terms of Use Privacy Policy About Cookies Legal Notice